Stocks of Research Tools, MDx Vendors Hit Hard in February | GenomeWeb

NEW YORK (GenomeWeb News) – The stocks of most of the 38 firms that comprise the GenomeWeb Daily News Index fell during the month of February, mirroring a drop for the tech-heavy Nasdaq market.

Overall, only nine of the companies in the Index closed the month up compared to January's close. Orchid Cellmark gained around 30 percent to close at $.70, while other notable gainers included CombiMatrix (+15 percent), Illumina (+15 percent), and Life Technologies (+14 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.